" Annan Hospital" was approved by the TFDA for treating patients with "Stage I to III solid cancers after ineffective conventional treatment" by autologous dendritic cell therapy on January 13, 2020

" Annan Hospital" was approved by the TFDA for treating patients with "Stage I to III solid cancers after ineffective conventional treatment" by autologous dendritic cell therapy on January 13, 2020

"Annan Hospital" is one of Ever Supreme’s collaborating medical institution.  It received approval by the Taiwan FDA for treating patients with "Stage I to III solid cancer after ineffective conventional treatment" by autologous dendritic cell on January 13, 2020. "  Autologous Dendritic cell (abbreviated as DC) treatment is available to patients who meet the conditions of admission with the following indications: Grade 1 to Grade 2 low-grade glioma and highly Grade 3 glioma, epithelial ovarian cancer, pancreatic cancer, prostate cancer, head and neck cancer, liver cancer, breast cancer, and colorectal cancer.